SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Raymond James Upgrades Blueprint Medicines to Strong Buy

Raymond James upgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Strong Buy.

Benzinga · -

Raymond James upgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Strong Buy.